The role of corticosteroids in adult respiratory distress syndrome caused by viridans group Streptococci bacteremia in neutropenic patients

Mediterranean Journal of Hematology and Infectious Diseases

Volumn 6, Issue 1, 2014, Pages

  Yacoub, Abraham T ^a   Mojica, Lysenia ^a   Jones, Lily ^b   Knab, Andrea ^b   Alrabaa, Sally ^b   Greene, John ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFALEXIN; CEFEPIME; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; HYDROCORTISONE; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; TRIMETHOPRIM; VANCOMYCIN;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; EARLY INTERVENTION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; STREPTOCOCCUS MITIS; STREPTOCOCCUS ORALIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926500986     PISSN: None     EISSN: 20353006     Source Type: Journal    
DOI: 10.4084/mjhid.2014.055     Document Type: Article

References (20)

1. Blijlevens NM, Donnelly JP, DePauw BE. Inflammatory response to mucosal barrier injury after myeloablative therapy in allogeneic stem cell transplant recipients. Bone Marrow Transplant. 2005;36(8):703-7. http://dx.doi.org/10.1038/sj.bmt.1705118 PMid:16062174
2. Blijlevens NM, Donnelly JP, de Pauw BE. Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect. 2001;7(Suppl 4):47-52. http://dx.doi.org/10.1046/j.1469-0691.2001.00058.x PMid:11688534
3. Han XY, Kamana M, Rolston K. Viridans Streptococci Isolated by Culture from Blood of Cancer Patients: Clinical and Microbiologic Analysis of 50 Cases. J Clin Microbiol. 2006;44(1):160-165. http://dx.doi.org/10.1128/JCM.44.1.160-165.2006 PMid:16390964 PMCid:PMC1351950
4. Ergin A. Classical and new approaches in Laboratory diagnosis of viridans streptococci. Mikrobiyol Bul. 2010;44(3):495-503. PMid:21064001
5. Danilatou V, Mantadakis E, Galanakis E, et al. Three cases of viridans group streptococcal bacteremia in children with febrile neutropenia and literature review. Scand J Infect Dis. 2003;35(11-12):873-6. http://dx.doi.org/10.1080/00365540310017159 PMid:14723365
6. Dompeling EC, Donnelly JP, Raemaekers JM, et al. Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine. Ann Hematol. 1994;69(2):69-71. http://dx.doi.org/10.1007/BF01698484 PMid:8080881
7. Doem CD, Burnham CAD. It's Not Easy Being Green: the Viridans Group Streptococci, with a Focus on Pediatric Clinical Manifetations. J Clin Microbiol. 2010;48(11):3829-3835. http://dx.doi.org/10.1128/JCM.01563-10 PMid:20810781 PMCid:PMC3020876
8. Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013;29(3):651-75. http://dx.doi.org/10.1016/j.ccc.2013.03.012 PMid:23830657
9. Hanage WP, Cohen J. Stimulation of cytokine release and adhesion molecule expression by products of Viridans streptococci. J Infect Dis. 2002;185(3):357-67. http://dx.doi.org/10.1086/338375 PMid:11807718
10. Ihendyane N, Sparrelid E, Wretlind B, et al. Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplant. 2004;33(1):79-85. http://dx.doi.org/10.1038/sj.bmt.1704302 PMid:14704660
11. Marron A, Carratala J, Gonzalez-Barca E, et al. Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis. 2000;31(5):1126-30. http://dx.doi.org/10.1086/317460 PMid:11073739
12. Reilly AF, Lange BJ. Infections with viridans group streptococci in children with cancer. Pediatr Blood Cancer. 2007;49(6):774-80. http://dx.doi.org/10.1002/pbc.21250 PMid:17588233
13. Ruescher TJ, Sodeifi A, Scrivani SJ, et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer. 1998;82(11):2275-81. http://dx.doi.org/10.1002/(SICI)1097-0142(19980601)82:112275::AID-CNCR253.0.CO;2-Q
14. Shenep JL. Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents. 2000;14(2):129-35. http://dx.doi.org/10.1016/S0924-8579(99)00172-7
15. Saito M, Kajiwara H, Iida K, et al. Systemic cytokine response in moribund mice of streptococcal toxic shock syndrome model. Microb Pathog. 2011;50(2):109-13. http://dx.doi.org/10.1016/j.micpath.2010.12.001 PMid:21146602
16. Han SB, Bae EY, Lee JW, et al. Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children. BMC Infect Dis. 2013;13:273. http://dx.doi.org/10.1186/1471-2334-13-273 PMid:23773209 PMCid:PMC3685537
17. Yao TC, Chiu CY, Tsai YC, et al. Viridans streptococcal bacteremia secondary to viral gastroenteritis in a healthy infant. Pediatr Int. 2010;52(2):e108-10. http://dx.doi.org/10.1111/j.1442-200X.2010.03054.x PMid:20500456
18. Gassas A, Grant R, Richardson S, et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 2004;22(7):1222-1227. http://dx.doi.org/10.1200/JCO.2004.09.108 PMid:15051769
19. Husain E, Whitehead S, Castell A, et al. Viridans streptococci bacteremia in children with malignancy: relevance of species identification and penicillin susceptibility. Pediatr Infect Dis J. 2005;24(6):563-566. http://dx.doi.org/10.1097/01.inf.0000164708.21464.03 PMid:15933573
20. Tunkel AR, Sepkowitz KA. Infections Caused by Viridans Streptococci in Patients with Neutropenia. Clin Infect Dis. 2002;34(11):1524-1529. http://dx.doi.org/10.1086/340402 PMid:12015700